|
Orthologous residues
|
|
MEF2A (human): T312‑p, MEF2A iso2 (human): T310‑p, MEF2A (mouse): T310‑p, MEF2A iso3 (mouse): T304‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, mutation of modification site, phosphoamino acid analysis, phosphopeptide mapping
|
|
Relevant cell lines - cell types - tissues:
293 (epithelial)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
sorbitol
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (process):
transcription, altered
|